EP-104IAR 25 mg

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the KneeNCT04120402EPRXPhase 2Completed2023-05-17Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.